Rune Labs

Rune Labs operates in the neuroscience and healthcare sector, focusing on developing software solutions for neuromodulation applications. The company aims to accelerate the next wave of brain-machine interfaces, which are designed to treat chronic neurological diseases such as Parkinson's, epilepsy, and Alzheimer's. By providing advanced software, Rune Labs helps restore mobility to paralyzed patients, speed up stroke recovery, and potentially enhance cognitive functions and mood control. The business primarily serves medical researchers, healthcare providers, and patients, operating within the global healthcare and medical technology markets. Rune Labs generates revenue through the development and licensing of its specialized software, which is integral to the functionality of neuromodulation devices.

Keywords: neuromodulation, brain-machine interfaces, chronic diseases, Parkinson's, epilepsy, Alzheimer's, stroke recovery, cognitive enhancement, healthcare, software solutions.